01
Migraine
Episodic, chronic, vestibular, hemiplegic, menstrual, refractory
The most common reason patients come to see me: recurrent moderate-to-severe attacks, often one-sided and pulsating, with nausea, light and sound sensitivity, and sometimes aura. Treatment ranges from an acute plan you can rely on to Botox and CGRP-directed prevention.
Includes
Episodic migraine
Attacks of moderate to severe head pain on fewer than 15 days a month, often one-sided and throbbing, worsened by activity and accompanied by nausea or sensitivity to light and sound. Attacks typically last 4 to 72 hours and leave a day of fatigue behind them.
DiagnosisDiagnosed clinically using ICHD-3 criteria and a careful attack history, supported by a headache diary that records frequency, triggers, and acute medication use. Imaging is reserved for red flags or an atypical pattern rather than used routinely.
TreatmentAn acute plan that works reliably — a triptan, gepant, or non-oral option for early nausea — plus preventive therapy when attacks are frequent or disabling: CGRP monoclonal antibodies, atogepant, candesartan, beta blockers, topiramate, or magnesium and riboflavin.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
Chronic migraine
Headache on 15 or more days a month for at least three months, with at least eight of those days meeting migraine features. Many patients describe a continuous background headache punctuated by full attacks.
DiagnosisConfirmed with a prospective headache diary over four to eight weeks, screening for medication overuse, sleep apnea, cervical contributors, and mood disorders that maintain the chronic pattern.
TreatmentOnabotulinumtoxinA on the full 31-site PREEMPT paradigm every 12 weeks, CGRP-targeted prevention, nerve blocks for flares, and a deliberate limit on acute medication so the pattern can unwind.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
Migraine with aura
Reversible neurologic symptoms — visual zig-zags or blind spots, numbness, tingling, or speech difficulty — that build over five to 60 minutes before or during the headache.
DiagnosisAura is diagnosed on the pattern of gradual spread and resolution. Sudden, negative, or persistent deficits require imaging and vascular assessment to exclude TIA, stroke, or a structural lesion.
TreatmentStandard acute and preventive migraine therapy, with gepants often preferred where vascular risk matters, plus counseling on estrogen-containing contraception and stroke-risk reduction.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
Vestibular migraine
Migraine that presents mainly as dizziness, spinning, unsteadiness, or motion sensitivity, sometimes with little or no head pain — frequently mistaken for an inner-ear disorder.
DiagnosisRequires recurrent vestibular episodes lasting minutes to hours alongside a current or past history of migraine, with audiology and vestibular testing used to exclude Meniere's disease and BPPV.
TreatmentMigraine prevention (venlafaxine, nortriptyline, topiramate, or a CGRP antibody) combined with vestibular rehabilitation and trigger stabilization around sleep and hydration.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
Hemiplegic migraine
A rare migraine subtype with reversible weakness on one side of the body as part of the aura, often with prolonged confusion, aphasia, or fever-like symptoms.
DiagnosisDiagnosis rests on documented motor aura with recovery, imaging to exclude stroke, and consideration of genetic testing for CACNA1A, ATP1A2, and SCN1A variants when there is a family history.
TreatmentPreventives such as verapamil, acetazolamide, or lamotrigine; triptans and ergots are generally avoided, and attack care focuses on antiemetics, hydration, and observation.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
Menstrual & hormonally driven migraine
Attacks clustered in the two days before through the third day of menstruation, often longer, more severe, and less responsive to usual acute treatment.
DiagnosisEstablished by a diary tracking attacks against the cycle over at least three months to separate pure menstrual migraine from menstrually related migraine.
TreatmentShort-term perimenstrual prevention with frovatriptan, naproxen, or magnesium, hormonal stabilization where appropriate, and continuous prevention when attacks extend beyond the cycle.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
Refractory migraine
Migraine that continues to disable despite adequate trials of multiple preventive classes, often after years of partial responses and side effects.
DiagnosisRe-examines the original diagnosis, verifies that each prior trial reached an adequate dose and duration, and looks for a missed secondary driver such as CSF pressure disorder, venous outflow obstruction, or medication overuse.
TreatmentCombination prevention (for example a CGRP antibody with Botox), interventional care including nerve blocks and infusion bridges, neuromodulation devices, and treatment of the systemic and sleep contributors that keep the pattern alive.
General information only. Some options are provided by other specialties through referral, and choices vary by patient and with current guidelines.
